Effects of soy isoflavones on endothelial function in healthy postmenopausal women
Authors:
- Nicola ColacurciNCNicola Colacurci
- Antonio ChiànteraACAntonio Chiàntera
- Felice FornaroFFFelice Fornaro
- Vito de NovellisVNVito de Novellis
- Daniela ManzellaDMDaniela Manzella
- Alessandro ArcielloAAAlessandro Arciello
- Vito ChiànteraVCVito Chiàntera
- Lucio ImprotaLILucio Improta
- Giuseppe PaolissoGPGiuseppe Paolisso
- 1 May 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Menopause
- Vol. 12 (3) , 299-307
Abstract
To evaluate the effects of soy isoflavone administration on endothelial function in healthy postmenopausal women. Sixty naturally postmenopausal women were randomly assigned to receive isoflavone or placebo tablets for 6 months. Endothelium-dependent vasodilatation was measured by brachial reactivity technique along with levels of plasma soluble intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), E-selectin, P-selectin and soluble thrombomodulin, von Willebrand factor, and tissue plasminogen activator. Differences between endothelium-dependent and endothelium-independent vasodilatation were assessed by evaluating brachial reactivity parameters after reactive hyperemia and after sublingual administration of nitroglycerin; furthermore, in the active group, the effect of isoflavones was also evaluated during the intra-arterial infusion of NG-monomethyl-L-arginine. Serum levels of lipids [high-density lipoprotein and low-density lipoprotein cholesterol, triglycerides and lipoprotein(a)] and hemostatic factors (prothrombin, fibrinogen, plasminogen activator inhibitor-1, and fibrin D-dimer) were also measured. To confirm the absorption of isoflavones, their blood concentrations were determined. Isoflavone treatment versus placebo was associated with a significant improvement in endothelium-dependent vasodilatation but had no impact on endothelial-independent arterial diameter and flow. Intra-arterial infusion of NG-monomethyl-L-arginine inhibited the significant effect of isoflavones on endothelium-mediated vasodilatation. Furthermore, isoflavone group experienced statistically significant reductions in plasma concentrations of ICAM-1, VCAM-1, and E-selectin. Levels of soluble thrombomodulin, von Willebrand factor, tissue plasminogen activator, lipids, and hemostatic factors did not change significantly throughout the study in both groups. Our findings suggest a positive influence of soy isoflavones on endothelial function in healthy postmenopausal women as evidenced by an improvement in endothelium-dependent vasodilatation and a reduction in plasma adhesion molecule levels.Keywords
This publication has 39 references indexed in Scilit:
- Estrogen plus Progestin and the Risk of Coronary Heart DiseaseNew England Journal of Medicine, 2003
- Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial functionBritish Journal of Nutrition, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- The Phytoestrogen Genistein Produces Acute Nitric Oxide–Dependent Dilation of Human Forearm Vasculature With Similar Potency to 17β-EstradiolCirculation, 2001
- Soy Protein and Cardiovascular DiseaseCirculation, 2000
- Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogenJournal of Clinical Investigation, 1999
- Circulating Adhesion Molecules VCAM-1, ICAM-1, and E-selectin in Carotid Atherosclerosis and Incident Coronary Heart Disease CasesCirculation, 1997
- Meta-Analysis of the Effects of Soy Protein Intake on Serum LipidsNew England Journal of Medicine, 1995
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Relative significance of dietary sources of nitrate and nitriteJournal of Agricultural and Food Chemistry, 1975